Effect of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Adolescents With Cystic Fibrosis

ETI may improve glucose tolerance in adolescents with CF by preserving insulin secretion. One-hour glucose during the OGTT helps to detect risk for AGT after ETI treatment.

Authors

Institutions

Publication Details

Journal
The Journal of Clinical Endocrinology & Metabolism
Published
2025-02-20
DOI
https://doi.org/10.1210/clinem/dgaf099
Citations
4
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
6.07

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Adolescents With Cystic Fibrosis

Katia Bessaci, Sophie Ramel, Nathalie Stremler, Laurent Mély et al.
4 citations
The Journal of Clinical Endocrinology & Metabolism
Cystic Fibrosis Research Advances
6.07
article

Effect of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Adolescents With Cystic Fibrosis

Katia Bessaci, Sophie Ramel, Nathalie Stremler, Laurent Mély, Harriet Corvol, Isabelle Sermet‐Gaudelus, Laure Cosson, S. Bui, Cinthia Rames, Asma Gabsi, Marie Giannantonio, Marie‐Laure Dalphin, Caroline Perisson, Aurélie Tatopoulos, Elsa Gachelin, A. Lustre, Anne-Marie Bonnel, M Héraud, Françoise Troussier, Manuëla Scalbert, Natascha Remus, Alfonso Galderisi, Alexia Letierce, Véronique Houdouin, V. Storni, D. Sahki, F. Huet, Nathalie Wizla, Eric Deneuville, Philippe Reix, Christophe Marguet, A. Besançon, Laurence Weiss
article en
4 citations

Abstract

ETI may improve glucose tolerance in adolescents with CF by preserving insulin secretion. One-hour glucose during the OGTT helps to detect risk for AGT after ETI treatment.

The Journal of Clinical Endocrinology & MetabolismVol. 110(11)
Hôpital Necker-Enfants Malades (FR), Inserm (FR), European University Viadrina (DE), Station Biologique de Roscoff (FR), Centre Hospitalier Universitaire de Bordeaux (FR), Yale University (US), Sorbonne Université (FR), Hôpital Femme Mère Enfant (FR), Institut Necker Enfants Malades (FR), Hôpital Armand-Trousseau (FR), Assistance Publique Hôpitaux de Marseille (FR), Centre Hospitalier Universitaire de Besançon (FR), Centre Hospitalier Universitaire de Tours (FR), Centre Hospitalier Universitaire Amiens-Picardie (FR), Hôpital Jeanne de Flandre (FR), Hôpital d'Enfants (FR), Centre Hospitalier Universitaire de Reims (FR), Centre hospitalier Bretagne Atlantique (FR), Hôpital Renée Sabran (FR), Hôpital Pellegrin (FR), Centre Hospitalier Universitaire d'Angers (FR), CHU Dijon Bourgogne (FR), Hôpital André Mignot (FR), Hôpital Robert-Debré (FR), Centre Hospitalier Universitaire de Clermont-Ferrand (FR), Fondation Lenval (FR), Peuplements végétaux et bioagresseurs en milieu tropical (RE), Hôpitaux Universitaires de Strasbourg (FR), Centre Hospitalier Universitaire de Rouen (FR), Centre Hospitalier Universitaire de Rennes (FR), Hôpital Intercommunal de Créteil (FR), Université de Rouen Normandie (FR), Université de Reims Champagne-Ardenne (FR)
Cystic Fibrosis Foundation
Good health and well-being
Openalex Percentile: Top 4%
Cystic Fibrosis Research Advances
6.07
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.